This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hillemann, D.
Right arrow Articles by Richter, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hillemann, D.
Right arrow Articles by Richter, E.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, August 2007, p. 2635-2640, Vol. 45, No. 8
0095-1137/07/$08.00+0     doi:10.1128/JCM.00521-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Evaluation of the GenoType MTBDRplus Assay for Rifampin and Isoniazid Susceptibility Testing of Mycobacterium tuberculosis Strains and Clinical Specimens{triangledown}

Doris Hillemann,* Sabine Rüsch-Gerdes, and Elvira Richter

Forschungszentrum Borstel, Nationales Referenzzentrum für Mykobakterien, D-23845 Borstel, Germany

Received 8 March 2007/ Returned for modification 6 May 2007/ Accepted 21 May 2007

The new GenoType MTBDRplus assay (Hain Lifescience GmbH, Nehren, Germany) was tested with 125 clinical isolates and directly with 72 smear-positive sputum specimens for its ability to detect rifampin (RMP) and isoniazid (INH) resistance in Mycobacterium tuberculosis complex (MTBC) strains. In total, 106 RMPr/INHr, 10 RMPs/INHr, and 80 RMPs/INHs MTBC strains were comparatively analyzed with the new and the old MTBDR assays. Besides the detection of mutations within the 81-bp hot spot region of rpoB and katG codon 315, the GenoType MTBDRplus assay is designed to detect mutations in the regulatory region of inhA. The applicability of the new assay directly to specimens was shown, since 71 of 72 results for smear-positive sputa and all 125 results for clinical isolates were interpretable and no discrepancies compared with the results of real-time PCR or DNA sequencing were obtained. In comparison to conventional drug susceptibility testing, both assays were able to identify RMP resistance correctly in 74 of 75 strains (98.7%) and 30 of 31 specimens (96.8%). The misidentification of RMP resistance was obtained for two strains containing rpoB P533L mutations. Compared to the old MTBDR assay, the new GenoType MTBDRplus assay enhanced the rate of detection of INH resistance from 66 (88.0%) to 69 (92.0%) among the 75 INH-resistant strains and 36 (87.8%) to 37 (90.2%) among the 41 specimens containing INH-resistant strains. Thus, the new GenoType MTBDRplus assay represents a reliable and upgraded tool for the detection of INH and RMP resistance in strains or directly from smear-positive specimens.

* Corresponding author. Mailing address: Forschungszentrum Borstel, Nationales Referenzzentrum für Mykobakterien, Parkallee 18, D-23845 Borstel, Germany. Phone: (49)-4537-188761. Fax: (49)-4537-188311. E-mail: dhillemann{at}fz-borstel.de

{triangledown} Published ahead of print on 30 May 2007.

Journal of Clinical Microbiology, August 2007, p. 2635-2640, Vol. 45, No. 8
0095-1137/07/$08.00+0     doi:10.1128/JCM.00521-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Lin, S.-Y. G., Desmond, E., Bonato, D., Gross, W., Siddiqi, S. (2009). Multicenter Evaluation of Bactec MGIT 960 System for Second-Line Drug Susceptibility Testing of Mycobacterium tuberculosis Complex. J. Clin. Microbiol. 47: 3630-3634 [Abstract] [Full Text]  
  • Cambau, E., Allerheiligen, V., Coulon, C., Corbel, C., Lascols, C., Deforges, L., Soussy, C.-J., Delchier, J.-C., Megraud, F. (2009). Evaluation of a New Test, GenoType HelicoDR, for Molecular Detection of Antibiotic Resistance in Helicobacter pylori. J. Clin. Microbiol. 47: 3600-3607 [Abstract] [Full Text]  
  • Hauck, Y., Fabre, M., Vergnaud, G., Soler, C., Pourcel, C. (2009). Comparison of two commercial assays for the characterization of rpoB mutations in Mycobacterium tuberculosis and description of new mutations conferring weak resistance to rifampicin. J Antimicrob Chemother 64: 259-262 [Abstract] [Full Text]  
  • Feuerriegel, S., Cox, H. S., Zarkua, N., Karimovich, H. A., Braker, K., Rusch-Gerdes, S., Niemann, S. (2009). Sequence Analyses of Just Four Genes To Detect Extensively Drug-Resistant Mycobacterium tuberculosis Strains in Multidrug-Resistant Tuberculosis Patients Undergoing Treatment. Antimicrob. Agents Chemother. 53: 3353-3356 [Abstract] [Full Text]  
  • Huang, W.-L., Chen, H.-Y., Kuo, Y.-M., Jou, R. (2009). Performance Assessment of the GenoType MTBDRplus Test and DNA Sequencing in Detection of Multidrug-Resistant Mycobacterium tuberculosis. J. Clin. Microbiol. 47: 2520-2524 [Abstract] [Full Text]  
  • Neonakis, I. K., Gitti, Z., Baritaki, S., Petinaki, E., Baritaki, M., Spandidos, D. A. (2009). Evaluation of GenoType Mycobacteria Direct Assay in Comparison with Gen-Probe Mycobacterium tuberculosis Amplified Direct Test and GenoType MTBDRplus for Direct Detection of Mycobacterium tuberculosis Complex in Clinical Samples. J. Clin. Microbiol. 47: 2601-2603 [Abstract] [Full Text]  
  • Springer, B., Lucke, K., Calligaris-Maibach, R., Ritter, C., Bottger, E. C. (2009). Quantitative Drug Susceptibility Testing of Mycobacterium tuberculosis by Use of MGIT 960 and EpiCenter Instrumentation. J. Clin. Microbiol. 47: 1773-1780 [Abstract] [Full Text]  
  • Evans, J., Stead, M. C., Nicol, M. P., Segal, H. (2009). Rapid genotypic assays to identify drug-resistant Mycobacterium tuberculosis in South Africa. J Antimicrob Chemother 63: 11-16 [Abstract] [Full Text]  
  • Springer, B., Calligaris-Maibach, R. C., Ritter, C., Bottger, E. C. (2008). Tuberculosis Drug Resistance in an Area of Low Endemicity in 2004 to 2006: Semiquantitative Drug Susceptibility Testing and Genotyping. J. Clin. Microbiol. 46: 4064-4067 [Abstract] [Full Text]  
  • Ling, D. I., Zwerling, A. A., Pai, M. (2008). GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis. Eur Respir J 32: 1165-1174 [Abstract] [Full Text]  
  • Lacoma, A., Garcia-Sierra, N., Prat, C., Ruiz-Manzano, J., Haba, L., Roses, S., Maldonado, J., Dominguez, J. (2008). GenoType MTBDRplus Assay for Molecular Detection of Rifampin and Isoniazid Resistance in Mycobacterium tuberculosis Strains and Clinical Samples. J. Clin. Microbiol. 46: 3660-3667 [Abstract] [Full Text]  
  • Akpaka, P. E., Baboolal, S., Clarke, D., Francis, L., Rastogi, N. (2008). Evaluation of Methods for Rapid Detection of Resistance to Isoniazid and Rifampin in Mycobacterium tuberculosis Isolates Collected in the Caribbean. J. Clin. Microbiol. 46: 3426-3428 [Abstract] [Full Text]  
  • Hoek, K. G. P., Gey van Pittius, N. C., Moolman-Smook, H., Carelse-Tofa, K., Jordaan, A., van der Spuy, G. D., Streicher, E., Victor, T. C., van Helden, P. D., Warren, R. M. (2008). Fluorometric Assay for Testing Rifampin Susceptibility of Mycobacterium tuberculosis Complex. J. Clin. Microbiol. 46: 1369-1373 [Abstract] [Full Text]  
  • Barnard, M., Albert, H., Coetzee, G., O'Brien, R., Bosman, M. E. (2008). Rapid Molecular Screening for Multidrug-Resistant Tuberculosis in a High-Volume Public Health Laboratory in South Africa. Am. J. Respir. Crit. Care Med. 177: 787-792 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»